Adding Pembrolizumab To Preoperative Radiotherapy and Surgery Improves DFS for Patients with Stage III Soft Tissue Sarcomas of the Extremity By Ogkologos - December 2, 2024 851 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SU2C-SARC032 study Source RELATED ARTICLESMORE FROM AUTHOR Daraxonrasib Shows Antitumour Activity Among Patients with Previously Treated RAS-mutated Pancreatic Ductal Adenocarcinoma FDA Approves Vepdegestrant for ER-positive, HER2-negative, ESR1-mutated Advanced or Metastatic Breast Cancer Aiming to support a robust regulatory ecosystem for driving cancer research in Europe, ESMO provides feedback to the public consultation on dataset descriptions under... MOST POPULAR 2021/22 in review: Charity looks to the future with ambitious new... July 21, 2022 Only a Quarter of Phase III Studies Demonstrated Improved QoL in... July 18, 2022 EMA Recommends Granting a Marketing Authorisation for Ripretinib for the Treatment... October 5, 2021 Popular Fitness Blogger Maria Kang Removed Her Breast Implants Due To... August 15, 2019 Load more HOT NEWS Lawmaker Dad Raises Awareness For RSV, An Illness He’d Never Heard... Higher Risk of Invasive Behaviour for Oncogenic Fusions–Driven Paediatric Thyroid Cancers Making Cancer Care More Equitable: A Cancer Survivor’s Story How My Metastatic Cancer Diagnosis Led Me to a Full-Time Career...
